EUVIMEDEUVIMED entdecken
Crossref

Update on current TAVI technology, indications, screening, and outcomes

A. Halapas, M. Chrissoheris, N. Bouboulis, J. Nicolaou, S. Pattakos, K. Spargias

Continuing Cardiology Education · 2016

DOI: 10.1002/cce2.20 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Continuing Cardiology Education, 2016. Verfasst von A. Halapas und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transcatheter aortic valve replacement ( TAVI ) is an established treatment for inoperable patients or patients at high surgical risk with severe aortic stenosis. Herein, we illustrate the key design features of the main new generation devices that are entering contemporary clinical practice, the labeled and off‐labeled indications, the basic principles of screening process, and the clinical outcomes of the TAVI procedure. Answer questions and earn CME: https://wileyhealthlearning.com/Activity2/4193543/Activity.aspx

Zitieren

APA

Halapas, A., Chrissoheris, M., Bouboulis, N., Nicolaou, J., Pattakos, S., & Spargias, K. (2016). Update on current TAVI technology, indications, screening, and outcomes. Continuing Cardiology Education. https://doi.org/10.1002/cce2.20

Vancouver

Halapas A, Chrissoheris M, Bouboulis N, Nicolaou J, Pattakos S, Spargias K. Update on current TAVI technology, indications, screening, and outcomes. Continuing Cardiology Education. 2016. doi:10.1002/cce2.20

BibTeX
@article{Halapas2016,
  author = {Halapas, A. and Chrissoheris, M. and Bouboulis, N. and Nicolaou, J. and Pattakos, S. and Spargias, K.},
  title = {Update on current TAVI technology, indications, screening, and outcomes},
  journal = {Continuing Cardiology Education},
  year = {2016},
  doi = {10.1002/cce2.20}
}
Kostenlos starten →